Search Results 81-90 of 820 for Zepbound

  1. https://www.mayoclinic.org/symptoms_all.xml

  2. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  3. Study to Evaluate Clinical Complications, Pattern of Kidney Function Decline and Identification of Clinical Variables Related to Progression of Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  5. Nosebleeds - Mayo Clinic

    Learn about possible causes of a nosebleed, self-care steps to take if you get one and when to seek medical care.

  6. https://www.mayoclinic.org/patient_consumer_faq.xml

  7. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  8. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  9. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  10. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

    About this study. The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC.